MedPage Today on MSN1d
Avoidable Cancers After Colonoscopy; Real-World Rinvoq Data; Drug Flops in IBS TrialResearchers in Gastroenterology evaluated strategies for preventing avoidable colorectal cancers after colonoscopy. In ...
The third-place slot marked another return to form. Novo Nordisk’s Wegovy reclaimed the seat it held in December, backed by ...
Many investors view the healthcare sector as a safe haven when the stock market is turbulent. Here are three no-brainer ...
JAK inhibitor Rinvoq (upadacitinib) has been backed by the CHMP as a 15mg, once-daily treatment for adults with GCA, an ...
GlobalData on MSN14d
CHMP recommends AbbVie’s Rinvoq be approved for adult GCAThe treatment has gained approval in the European Union (EU) for a range of conditions, including psoriatic arthritis, ...
Right now, Rinvoq is approved in the European Union and the U.S. for the treatment of adults with radiographic axial spondylarthritis, nonradiographic axial spondylarthritis, psoriatic arthritis, ...
Pharma brands achieved the most impressions from ABC and saw a year-over-year increase in impressions from cable channels like Fox News, CNN and MSNBC.
RINVOQ is approved in the European Union (EU) for the treatment of adults with radiographic axial spondylarthritis, nonradiographic axial spondylarthritis, psoriatic arthritis, rheumatoid ...
Feb. 28, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback